JP2006515748A - リウマチ様関節炎の治療のための組成物と方法 - Google Patents

リウマチ様関節炎の治療のための組成物と方法 Download PDF

Info

Publication number
JP2006515748A
JP2006515748A JP2004552090A JP2004552090A JP2006515748A JP 2006515748 A JP2006515748 A JP 2006515748A JP 2004552090 A JP2004552090 A JP 2004552090A JP 2004552090 A JP2004552090 A JP 2004552090A JP 2006515748 A JP2006515748 A JP 2006515748A
Authority
JP
Japan
Prior art keywords
seq
sequence number
sequence
polypeptide
pro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004552090A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006515748A5 (https=
Inventor
アレックス アッバス，
サラ ボーダリー，
ヒラリー クラーク，
トーマス ディ． ウー，
ジル ショーンフェルド，
ウィリアム， アイ． ウッド，
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of JP2006515748A publication Critical patent/JP2006515748A/ja
Publication of JP2006515748A5 publication Critical patent/JP2006515748A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rehabilitation Therapy (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP2004552090A 2002-11-12 2003-11-12 リウマチ様関節炎の治療のための組成物と方法 Pending JP2006515748A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42593102P 2002-11-12 2002-11-12
PCT/US2003/036002 WO2004043397A2 (en) 2002-11-12 2003-11-12 Compositions and methods for the treatment of rheumatoid arthritis

Publications (2)

Publication Number Publication Date
JP2006515748A true JP2006515748A (ja) 2006-06-08
JP2006515748A5 JP2006515748A5 (https=) 2006-12-07

Family

ID=32313075

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004552090A Pending JP2006515748A (ja) 2002-11-12 2003-11-12 リウマチ様関節炎の治療のための組成物と方法

Country Status (6)

Country Link
US (1) US20090186018A1 (https=)
EP (1) EP1578368A4 (https=)
JP (1) JP2006515748A (https=)
AU (1) AU2003290743A1 (https=)
CA (1) CA2503759A1 (https=)
WO (1) WO2004043397A2 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008500009A (ja) * 2003-03-03 2008-01-10 ジェネンテック・インコーポレーテッド 全身性エリテマトーデスの治療のための組成物と方法

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0414325D0 (en) * 2004-06-25 2004-07-28 Celltech R&D Ltd A protein involved in cancer
JP6162707B2 (ja) 2011-10-24 2017-07-12 ハロザイム インコーポレイテッド 抗ヒアルロナン剤治療のためのコンパニオン診断およびその使用方法
EP3219722B1 (en) * 2016-03-14 2019-03-27 Hung Guang Biotech Co. Ltd. Modified colostrum protein and application thereof
CA3051839A1 (en) 2017-02-17 2018-08-23 Bristol-Myers Squibb Company Antibodies to alpha-synuclein and uses thereof
WO2022221319A2 (en) * 2021-04-12 2022-10-20 Graphite Bio, Inc. Methods and compositions for production of genetically modified primary cells

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989009777A1 (en) * 1988-04-08 1989-10-19 Arch Development Corporation Methods and materials relating to dna binding proteins

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992010591A1 (en) * 1990-12-14 1992-06-25 Cell Genesys, Inc. Chimeric chains for receptor-associated signal transduction pathways
US20040167065A1 (en) * 2000-09-29 2004-08-26 Lal Preeti G. Transferases
EP1293569A3 (en) * 2001-09-14 2004-03-31 Research Association for Biotechnology Full-length cDNAs
CA2460621A1 (en) * 2001-09-19 2003-03-27 Nuvelo, Inc. Novel nucleic acids and polypeptides

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989009777A1 (en) * 1988-04-08 1989-10-19 Arch Development Corporation Methods and materials relating to dna binding proteins
US5206152A (en) * 1988-04-08 1993-04-27 Arch Development Corporation Cloning and expression of early growth regulatory protein genes

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008500009A (ja) * 2003-03-03 2008-01-10 ジェネンテック・インコーポレーテッド 全身性エリテマトーデスの治療のための組成物と方法

Also Published As

Publication number Publication date
US20090186018A1 (en) 2009-07-23
WO2004043397A2 (en) 2004-05-27
WO2004043397A3 (en) 2006-08-24
AU2003290743A1 (en) 2004-06-03
CA2503759A1 (en) 2004-05-27
EP1578368A4 (en) 2008-01-23
EP1578368A2 (en) 2005-09-28

Similar Documents

Publication Publication Date Title
JP5401001B2 (ja) 免疫関連疾患の治療のための新規組成物と方法
JP4901747B2 (ja) 免疫関連疾患の治療のための新規組成物と方法
JP2006515747A (ja) 免疫関連疾患の治療のための組成物と方法
JP2006517785A (ja) 免疫関連疾患の治療のための新規組成物と方法
JP2006516094A (ja) ナチュラルキラー細胞関連疾患の治療のための組成物と方法
JP2010220614A (ja) 免疫関連疾患の治療のための組成物と方法
JP2010162016A (ja) 乾癬の治療のための新規組成物と方法
JP2011172580A (ja) 免疫関連疾患の治療のための新規組成物と方法
JP2013240329A (ja) 全身性エリテマトーデスの治療のための組成物と方法
JP2010088434A (ja) 免疫関連疾患の治療のための新規組成物と方法
JP2006515167A (ja) 免疫関連疾患の治療のための新規組成物と方法
JP2011177176A (ja) 乾癬の治療のための新規組成物と方法
JP2013051961A (ja) 免疫関連疾患の治療のための新規組成物と方法
JP2008301810A (ja) 免疫関連疾患を治療するための組成物及び方法
JP2010046065A (ja) インターロイキン−８と相同なポリペプチドとその治療用途
JP2006521810A (ja) 免疫関連疾患の治療のための新規組成物と方法
JP2005519590A (ja) 免疫関連疾患の治療のための組成物及び方法
JP2013048621A (ja) 免疫関連疾患の治療のための組成物と方法
JP2006515748A (ja) リウマチ様関節炎の治療のための組成物と方法
JP3988821B2 (ja) 免疫関連疾患を治療するための組成物及び方法
JP2006519582A (ja) 乾癬の治療のための新規組成物と方法
JP2006511210A (ja) 免疫関連疾患の治療のための新規組成物と方法
EP1923400A1 (en) Compositions and methods for the treatment of systemic lupus erythematosis
HK1118838A (en) Compositions and methods for the treatment of systemic lupus erythematosis

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20061023

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20061023

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20091117

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20100511